Search - Université Paris Cité Access content directly

Filter your results

29 Results
Author: personID (integer) : 765692

The Lymphoid Variant of Hypereosinophilic Syndrome

Guillaume Lefevre , Marie-Christine Copin , Delphine Staumont-Sallé , Martine Avenel-Audran , Hélène Aubert et al.
Medicine, 2014, 93 (17), pp.255-266. ⟨10.1097/MD.0000000000000088⟩
Journal articles hal-02083252v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1

Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial

Salim Kanoun , Alina Berriolo-Riedinger , Ilan Tal, , V Edeline, , Anne Ségolène Cottereau et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2016, Barcelone, Spain. pp.S125-S126 ; Meeting Abstract: OP406
Conference papers hal-01472426v1

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

Pierre Sujobert , Gilles Salles , Emmanuel Bachy
Hematology/Oncology Clinics of North America, 2016, 30 (6), pp.1163-1177. ⟨10.1016/j.hoc.2016.07.001⟩
Journal articles hal-01800003v1
Image document

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

Sylvain Carras , Dimitri Chartoire , Sylvain Mareschal , Maël Heiblig , Antoine Marçais et al.
The Journal of clinical investigation, 2021, 131 (13), pp.e139675. ⟨10.1172/jci139675⟩
Journal articles inserm-03280949v1
Image document

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

Pierre Sujobert , Yannick Le Bris , Laurence de Leval , Audrey Gros , Jean Philippe Merlio et al.
HemaSphere, 2019, 3 (1), pp.e169. ⟨10.1097/HS9.0000000000000169⟩
Journal articles hal-02397399v1

CD1d-restricted peripheral T cell lymphoma in mice and humans

Emmanuel Bachy , Mirjam Urb , Shilpi Chandra , Rémy Robinot , Gabriel Bricard et al.
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
Journal articles hal-01305487v1

Definition of a minimal genes set for mature lymphoid blood diseases

Pierre Sujobert , Yannick Le Bris , Laurence de Leval , Audrey Gros , Jean Philippe Merlio et al.
Hématologie, 2018, 24 (1), pp.27-59. ⟨10.1684/hma.2018.1315⟩
Journal articles hal-01870189v1

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Marie-Hélène Delfau-Larue , Wolfram Klapper , Françoise Berger , Fabrice Jardin , Josette Brière et al.
Blood, 2015, 126 (5), pp.604-611. ⟨10.1182/blood-2015-02-628792⟩
Journal articles hal-02331700v1

T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?

Pierre Raynaud , Sylvie Caulet-Maugendre , Charles Foussard , Gilles Salles , Anne Moreau et al.
Human Pathology, 2008, 39 (2), pp.194-200. ⟨10.1016/j.humpath.2007.05.026⟩
Journal articles istex hal-00678052v1

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Sydney Dubois , Pierre-Julien Viailly , Elodie Bohers , Philippe Bertrand , Philippe Ruminy et al.
Clinical Cancer Research, 2017, 23 (9), pp.2232-2244. ⟨10.1158/1078-0432.CCR-16-1922⟩
Journal articles hal-01526582v1

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

Clémentine Sarkozy , Sophie Kaltenbach , Pierre Faurie , Danielle Canioni , Françoise Berger et al.
Genes, Chromosomes & Cancer, 2017, 56, pp.221-230. ⟨10.1002/gcc.22428⟩
Journal articles hal-01795702v1

Mutational landscape of gray zone lymphoma

Clémentine Sarkozy , Stacy Hung , Elizabeth Chavez , Gerben Duns , Katsuyoshi Takata et al.
Blood, 2021, 137 (13), pp.1765-1776. ⟨10.1182/blood.2020007507⟩
Journal articles hal-03257279v1

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

Hervé Tilly , Franck Morschhauser , Olivier Casasnovas , Thierry Jo Molina , Pierre Feugier et al.
The Lancet Haematology, 2018, 5 (9), pp.e403-e410. ⟨10.1016/S2352-3026(18)30131-5⟩
Journal articles hal-02329073v1
Image document

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Franck Morschhauser , Gilles Salles , Steven Le Gouill , Hervé Tilly , Catherine Thieblemont et al.
Blood, 2018, 132 (14), pp.1486 - 1494. ⟨10.1182/blood-2018-05-853499⟩
Journal articles hal-01928199v1

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Franck Morschhauser , Christian Recher , Noël Milpied , Remy Gressin , Gilles Salles et al.
Annals of Oncology, 2012, 23 (10), pp.2687-95. ⟨10.1093/annonc/mds202⟩
Journal articles inserm-00862711v1

Impact of 18F-fluorodeoxyglucose Positron Emission Tomography Response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy : a prospective study from the group d'Etudes des lymphomes de l'adulte and GOELAMS.

Jehan Dupuis , Alina Berriolo-Riedinger , Anne Julian , Pauline Brice , Christelle Tychyj et al.
Journal of Clinical Oncology, 2012, 10 (35), pp.4317-22
Journal articles hal-00941072v1

BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1

Lorric Delage , Mireille Lambert , Emilie Bardel , Cindy Kundlacz , Dimitri Chartoire et al.
Journal articles hal-03863355v1

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial

Natacha Heutte , Henning Flechtner , Nicolas Mounier , Wilhelmina Am Mellink , Jacobus Meerwaldt et al.
Lancet Oncology, 2009, 10 (12), pp.1160-1170. ⟨10.1016/S1470-2045(09)70258-X⟩
Journal articles istex hal-02359039v1
Image document

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Emmanuel Bachy , Roch Houot , Franck Morschhauser , Anne Sonet , Pauline Brice et al.
Haematologica, 2013, 98 (7), pp.1107-14. ⟨10.3324/haematol.2012.082412⟩
Journal articles hal-00933219v1
Image document

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet , Bruno Tesson , Jean-Philippe Jais , Andrew Feldman , Laura Magnano et al.
Lancet Oncology, 2018, 19 (4), pp.549 - 561. ⟨10.1016/S1470-2045(18)30102-5⟩
Journal articles hal-01788996v1
Image document

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Emmanuel Bachy , Roch Houot , Pierre Feugier , Krimo Bouabdallah , Reda Bouabdallah et al.
Blood, 2022, 139 (15), pp.2338-2346. ⟨10.1182/blood.2021013526⟩
Journal articles hal-03679319v1

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma

Sylvain Mareschal , Sydney Dubois , Pierre-Julien Viailly , Philippe Bertrand , Elodie Bohers et al.
Genes, Chromosomes & Cancer, 2016, 55 (3), pp.251-267. ⟨10.1002/gcc.22328⟩
Journal articles istex hal-01237083v1
Image document

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study

Sydney Dubois , Pierre-Julien Viailly , Sylvain Mareschal , Elodie Bohers , Philippe Bertrand et al.
Clinical Cancer Research, 2016, 22 (12), pp.2919--2928. ⟨10.1158/1078-0432.CCR-15-2305⟩
Journal articles hal-01343064v1

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie-Bergman , Peggy Cuillière-Dartigues , Maryse Baia , Josette Brière , Richard Delarue et al.
Blood, 2015, 126 (22), pp.2466-2474. ⟨10.1182/blood-2015-05-647602⟩
Journal articles hal-02331572v1

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thieblemont , Hervé Tilly , Maria Gomes Da Silva , Rene-Olivier Casasnovas , Christophe Fruchart et al.
Journal of Clinical Oncology, 2017, 35 (22), pp.2473-2481. ⟨10.1200/JCO.2017.72.6984⟩
Journal articles hal-01609346v1
Image document

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association

Clémentine Sarkozy , Thierry Molina , Hervé Ghesquières , Anne-Sophie Michallet , Jehan Dupuis et al.
Haematologica, 2016, 102 (1), pp.150 - 159. ⟨10.3324/haematol.2016.152256⟩
Journal articles hal-01471621v1

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.

Philippe Colombat , Nicole Brousse , Gilles Salles , Franck Morschhauser , Pauline Brice et al.
Annals of Oncology, 2012, 23 (9), pp.2380-5. ⟨10.1093/annonc/mds177⟩
Journal articles inserm-00821113v1
Image document

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

Franck Morschhauser , Steven Le Gouill , Pierre Feugier , Sarah Bailly , Emmanuelle Nicolas-Virelizier et al.
The Lancet Haematology, 2019, 6 (8), pp.e429-e437. ⟨10.1016/S2352-3026(19)30089-4⟩
Journal articles hal-02586078v1